HMPV seasonal outbreak in China (2024–present) | |
---|---|
Disease | HMPV |
Virus strain | Metapneumovirus |
Location | China |
The HMPV seasonal outbreak in China, caused by respiratory syndrome human metapneumovirus (HMPV), began with an increase in cases in Beijing, China in December 2024.
It was brought to public attention when the Chinese Center for Disease Control and Prevention published data showing that respiratory infections of human metapneumovirus had risen significantly in the week of 16 to 22 December 2024. [1] However, WHO noted that the surge in cases of HMPV are within the range expected for this time of year during the northern hemisphere winter. [2]
As of 2006 [update] , HMPV had a worldwide distribution. [3] In late 2024, human metapneumovirus was linked to 6.2 percent of positive respiratory illness tests and 5.4 percent of respiratory-illness hospitalizations in China, more than COVID-19, rhinovirus or adenovirus. [4] [ better source needed ] Cases were reported in Hong Kong, with a lower growth rate than that of mainland China. [5] [6]
Kan Biao, head of the Chinese Center for Disease Control and Prevention (CCDC)'s National Institute for Communicable Disease Control and Prevention, announced that the rate of HMPV among children ages 14 and under was on the rise in China in late 2024. [7] Chinese health officials stated that the surge was consistent with overall seasonal trends. [8]
Cases were reported in Malaysia, with an increase of 102 cases from 225 cases in 2023 to 327 cases in 2024. [9] [10] The Malaysian Ministry of Health has urged the population to remain vigilant, using masks if infected and adopting other ways to avoid contagion. [11]
The symptoms of HMPV are often similar to that of the common cold, including cough, fever, runny or stuffy nose, sore throat, wheezing, shortness of breath and rash. [12] HMPV activity typically peaks during late winter and spring, similar to other respiratory infections. [13] Most people with HMPV have mild upper respiratory symptoms similar to the common cold and recover from HMPV in about 7 to 10 days without any complications. [2] However, certain groups face a higher risk of severe complications:
HMPV does not have a specific antiviral medication. Treatment primarily aims at managing symptoms and preventing complications. [14] Rest and hydration, over-the-counter medications to control body-aches and fevers are recommended for mild conditions, while some cases may require oxygen therapy and hospitalization. [14] Severe cases of hMPV as with individuals who are immunocompromised are treated with Ribavirin and IVIG. [15] [16]
No conclusive studies have proven the true method of transmission, but it is likely through contact with contaminated secretions, via droplet, aerosol, or fomite vectors.
HMPV belongs to the subfamily Pneumovirinae (genus Metapneumovirus ). It is an enveloped, nonfragmented, negative-sense single-stranded RNA virus. [17]
Real-time polymerase chain reaction (RT-qPCR) tests are widely used in clinical HMPV detection due to their sensitivity, ability to give quick results (1–3 h) [18] and ability to quantify the viral load which can asses the severity of the infection. RT-qPCR methods provide higher sensitivity, and lower probability of contamination compared to the conventional RT-PCR methods, thus it is considered as the gold standard diagnostic approach. [18] It works by quantifying the viral load of HMPV to then confirm the presence of it once it reaches a threshold.
Reverse transcription polymerase chain reaction (RT-PCR) assays have been widely applied for viral molecular detection, including HMPV. It works by checking for HMPV-specific cDNA, which is amplified during the PCR process. It has also been widely used for performing epidemiological investigation of HMPV. RT-PCR assays for pathogen detection display lower sensitivity compared with RT-qPCR methods, which needs complex instruments. Thus, RT-PCR methods have been less applied for HMPV-clinical detection in recent years. [18]
Loop-Mediated Isothermal Amplification (LAMP) is one of the most widely used isothermal methods in pathogen diagnosis. It eliminates the thermal-cycling that exists in PCR, which requires complex equipment. The detection results of the LAMP method can be observed and judged via the naked eyes. But compared to PCR based tests, the cost of LAMP is higher. [18]
Virus isolation from the clinical samples is regarded as a gold standard for pathogen diagnosis, which is the initial step to developing vaccines and investigating viral pathogenesis. However, it is high cost and time-consuming, and low isolation rate, and requires complex instruments and trained workers. [18]
A Chest X-ray or bronchoscopy are also used to look for changes or pneumonia in the airways of your lungs. [19]
Moderna has conducted a clinical trial for a candidate modRNA vaccine against metapneumovirus. As of October 2019, the vaccine candidate has passed through phase I. [20] [21]
The Union Health Secretary of India noted that there is no cause of concern for the public from HMPV. She advised states to strengthen and review the influenza-like illness (ILI)/severe acute respiratory infections (SARI) surveillance, to enhance Information, Education and Communication (IEC) and awareness among the population regarding prevention of transmission of the virus with simple measures such as washing hands often with soap and water. She reiterated that an increase in respiratory illnesses is usually seen during the winter months. She also stated that India is well prepared for any potential surge in respiratory illness cases. [22]
In Pakistan, the National Institute of Health stated that HMPV had been reported in Pakistan since 2001, with 21 cases at Pakistan Institute of Medical Sciences (PIMS) in 2015. In early January 2025, the Pakistani government was closely monitoring the situation in China, and called a meeting of the National Command and Operation Center (NCOC). [23] [24] [25]
In late 2024, human metapneumovirus was linked to 6.2 percent of positive respiratory illness tests and 5.4 percent of respiratory-illness hospitalizations in China, more than COVID-19, rhinovirus or adenovirus. [26] [4]
Pneumonia is an inflammatory condition of the lung primarily affecting the small air sacs known as alveoli. Symptoms typically include some combination of productive or dry cough, chest pain, fever, and difficulty breathing. The severity of the condition is variable.
Mumps is a highly contagious viral disease caused by the mumps virus. Initial symptoms of mumps are non-specific and include fever, headache, malaise, muscle pain, and loss of appetite. These symptoms are usually followed by painful swelling around the side of the face, which is the most common symptom of a mumps infection. Symptoms typically occur 16 to 18 days after exposure to the virus. About one-third of people with a mumps infection do not have any symptoms (asymptomatic).
Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the virus SARS-CoV-1, the first identified strain of the SARS-related coronavirus. The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak. In the 2010s, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.
Fifth disease, also known as erythema infectiosum and slapped cheek syndrome, is a common and contagious disease caused by infection with parvovirus B19. This virus was discovered in 1975 and can cause other diseases besides fifth disease. Fifth disease typically presents as a rash and is most common in children. While parvovirus B19 can affect people of all ages, only two out of ten individuals will present with symptoms.
Influenza A virus (IAV) is the only species of the genus Alphainfluenzavirus of the virus family Orthomyxoviridae. It is a pathogen with strains that infect birds and some mammals, as well as causing seasonal flu in humans. Mammals in which different strains of IAV circulate with sustained transmission are bats, pigs, horses and dogs; other mammals can occasionally become infected.
Respiratory syncytial virus (RSV), also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. Its name is derived from the large cells known as syncytia that form when infected cells fuse.
Human metapneumovirus is a negative-sense single-stranded RNA virus of the family Pneumoviridae and is closely related to the avian metapneumovirus (AMPV) subgroup C. It was isolated for the first time in 2001 in the Netherlands by using the RAP-PCR technique for the identification of unknown viruses growing in cultured cells. As of 2016, it was the second most common cause—after respiratory syncytial virus (RSV)—of acute respiratory tract illness in otherwise-healthy children under the age of 5 in a large US outpatient clinic.
Human parainfluenza viruses (HPIVs) are the viruses that cause human parainfluenza. HPIVs are a paraphyletic group of four distinct single-stranded RNA viruses belonging to the Paramyxoviridae family. These viruses are closely associated with both human and veterinary disease. Virions are approximately 150–250 nm in size and contain negative sense RNA with a genome encompassing about 15,000 nucleotides.
Avian infectious bronchitis (IB) is an acute and highly contagious respiratory disease of chickens. The disease is caused by avian infectious bronchitis virus (IBV), a coronavirus, and characterized by respiratory signs including gasping, coughing, sneezing, tracheal rales, and nasal discharge. In young chickens, severe respiratory distress may occur. In layers, respiratory distress, nephritis, decrease in egg production, and loss of internal and external egg quality are reported.
Oropouche fever is a tropical viral infection which can infect humans. It is transmitted by biting midges and mosquitoes, from a natural reservoir which includes sloths, non-human primates, and birds. The disease is named after the region where it was first discovered and isolated in 1955, by the Oropouche River in Trinidad and Tobago. Oropouche fever is caused by the Oropouche virus (OROV), of the Bunyavirales order of viruses.
Viral pneumonia is a pneumonia caused by a virus. Pneumonia is an infection that causes inflammation in one or both lungs. The pulmonary alveoli fill with fluid or pus making it difficult to breathe. Pneumonia can be caused by bacteria, viruses, fungi or parasites. Viruses are the most common cause of pneumonia in children, while in adults bacteria are a more common cause.
Community-acquired pneumonia (CAP) refers to pneumonia contracted by a person outside of the healthcare system. In contrast, hospital-acquired pneumonia (HAP) is seen in patients who have recently visited a hospital or who live in long-term care facilities. CAP is common, affecting people of all ages, and its symptoms occur as a result of oxygen-absorbing areas of the lung (alveoli) filling with fluid. This inhibits lung function, causing dyspnea, fever, chest pains and cough.
Adenovirus infection is a contagious viral disease, caused by adenoviruses, commonly resulting in a respiratory tract infection. Typical symptoms range from those of a common cold, such as nasal congestion, rhinitis, and cough, to difficulty breathing as in pneumonia. Other general symptoms include fever, fatigue, muscle aches, headache, abdominal pain and swollen neck glands. Onset is usually two to fourteen days after exposure to the virus. A mild eye infection may occur on its own, combined with a sore throat and fever, or as a more severe adenoviral keratoconjunctivitis with a painful red eye, intolerance to light and discharge. Very young children may just have an earache. Adenovirus infection can present as a gastroenteritis with vomiting, diarrhea, and abdominal pain, with or without respiratory symptoms. However, some people have no symptoms.
Influenza, commonly known as the flu, is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin one to four days after exposure to the virus and last for about two to eight days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia from the virus or a subsequent bacterial infection. Other complications include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.
Influenza-like illness (ILI), also known as flu-like syndrome or flu-like symptoms, is a medical diagnosis of possible influenza or other illness causing a set of common symptoms. These include fever, shivering, chills, malaise, dry cough, loss of appetite, body aches, nausea, and sneezing typically in connection with a sudden onset of illness. In most cases, the symptoms are caused by cytokines released by immune system activation, and are thus relatively non-specific.
The 2009 swine flu pandemic, caused by the H1N1/swine flu/influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, was the third recent flu pandemic involving the H1N1 virus. The first identified human case was in La Gloria, Mexico, a rural town in Veracruz. The virus appeared to be a new strain of H1N1 that resulted from a previous triple reassortment of bird, swine, and human flu viruses which further combined with a Eurasian pig flu virus, leading to the term "swine flu".
Avian metapneumovirus (aMPV), also known as turkey rhinotracheitis or swollen head syndrome, causes a variety of disease syndromes in birds, depending on the bird species and virus type.
Bayou virus (BAYV) is a species of Orthohantavirus comprising enveloped and spherical viruses. It was first identified in 1993 in Louisiana and later confirmed by other investigators. BAYV was recognized as a distinct form of hantavirus disease, now known as hantavirus pulmonary syndrome (HPS). It now represents the second most common hantavirus in the United States behind the Sin Nombre virus. In 1996, the marsh rice rat, which is seen in marshes in the southeast and mountain streams in the northeast, was identified as the natural reservoir of the virus. Due to the virus being first identified in Louisiana, this indicated the virus to be widespread throughout the Southeastern United States. This hantavirus disease is known as a severe and sometimes fatal respiratory disease, and HPS has a case-rate fatality of almost 50%.
Middle East respiratory syndrome (MERS) is a viral respiratory infection caused by Middle East respiratory syndrome–related coronavirus (MERS-CoV). Symptoms may range from none, to mild, to severe depending on age and risk level. Typical symptoms include fever, cough, diarrhea, and shortness of breath. The disease is typically more severe in those with other health problems.
Aichivirus A formerly Aichi virus (AiV) belongs to the genus Kobuvirus in the family Picornaviridae. Six species are part of the genus Kobuvirus, Aichivirus A-F. Within Aichivirus A, there are six different types including human Aichi virus, canine kobuvirus, murine kobuvirus, Kathmandu sewage kobuvirus, roller kobuvirus, and feline kobuvirus. Three different genotypes are found in human Aichi virus, represented as genotype A, B, and C.